The therapeutic age of the neonatal Fc receptor

M Pyzik, LK Kozicky, AK Gandhi… - Nature Reviews …, 2023 - nature.com
IgGs are essential soluble components of the adaptive immune response that evolved to
protect the body from infection. Compared with other immunoglobulins, the role of IgGs is …

The neonatal Fc receptor (FcRn): a misnomer?

M Pyzik, KMK Sand, JJ Hubbard, JT Andersen… - Frontiers in …, 2019 - frontiersin.org
Antibodies are essential components of an adaptive immune response. Immunoglobulin G
(IgG) is the most common type of antibody found in circulation and extracellular fluids …

HLA-G: An important mediator of maternal-fetal immune-tolerance

B Zhuang, J Shang, Y Yao - Frontiers in Immunology, 2021 - frontiersin.org
Maternal-fetal immune-tolerance occurs throughout the whole gestational trimester, thus a
mother can accept a genetically distinct fetus without immunological aggressive behavior …

Review of immune tolerance induction in hemophilia A

SJ Schep, REG Schutgens, K Fischer, ML Boes - Blood Reviews, 2018 - Elsevier
At first sight the bleeding disorder hemophilia A seems to have little in common with immune
disorders, but immunology research intersects with other disciplines including hematology …

Tolerating factor VIII: recent progress

S Lacroix-Desmazes, J Voorberg, D Lillicrap… - Frontiers in …, 2020 - frontiersin.org
Development of neutralizing antibodies against biotherapeutic agents administered to
prevent or treat various clinical conditions is a longstanding and growing problem faced by …

[HTML][HTML] The European hematology association roadmap for European hematology research: a consensus document

A Engert, C Balduini, A Brand, B Coiffier… - …, 2016 - ncbi.nlm.nih.gov
Abstract The European Hematology Association (EHA) Roadmap for European Hematology
Research highlights major achievements in diagnosis and treatment of blood disorders and …

In translation: FcRn across the therapeutic spectrum

T Qi, Y Cao - International Journal of Molecular Sciences, 2021 - mdpi.com
As an essential modulator of IgG disposition, the neonatal Fc receptor (FcRn) governs the
pharmacokinetics and functions many therapeutic modalities. In this review, we thoroughly …

Immune complications and their management in inherited and acquired bleeding disorders

VR Arruda, D Lillicrap… - Blood, The Journal of the …, 2022 - ashpublications.org
Disorders of coagulation, resulting in serious risks for bleeding, may be caused by
autoantibody formation or by mutations in genes encoding coagulation factors. In the latter …

[HTML][HTML] Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice

S Krishnamoorthy, T Liu, D Drager… - Cellular …, 2016 - Elsevier
Anti-factor VIII (FVIII) antibodies is a major complication of FVIII replacement therapy for
hemophilia A. We investigated the immune response to recombinant human factor VIII Fc …

Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors—a retrospective analysis

M Carcao, A Shapiro, JM Staber, N Hwang… - …, 2018 - Wiley Online Library
Introduction Immune tolerance induction (ITI) is the gold standard for eradication of factor VIII
inhibitors in severe haemophilia A; however, it usually requires treatment for extended …